Total Payments
$2,313
2024 Payments
$74.58
Companies
17
Transactions
157
Medicare Patients
3,291
Medicare Billing
$353,477
Payment Breakdown by Category
Food & Beverage$2,306 (99.7%)
Education$7.29 (0.3%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,306 | 156 | 99.7% |
| Education | $7.29 | 1 | 0.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $930.30 | 60 | $0 (2024) |
| Janssen Biotech, Inc. | $265.42 | 16 | $0 (2022) |
| Valeant Pharmaceuticals North America LLC | $248.85 | 9 | $0 (2017) |
| Allergan Inc. | $196.95 | 29 | $0 (2018) |
| PFIZER INC. | $168.62 | 11 | $0 (2023) |
| Gilead Sciences, Inc. | $120.00 | 1 | $0 (2019) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $108.46 | 8 | $0 (2021) |
| INTERCEPT PHARMACEUTICALS, INC. | $61.57 | 4 | $0 (2023) |
| Merck Sharp & Dohme LLC | $48.46 | 4 | $0 (2022) |
| Takeda Pharmaceuticals America, Inc. | $33.40 | 6 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $74.58 | 4 | ABBVIE INC. ($74.58) |
| 2023 | $341.35 | 21 | ABBVIE INC. ($227.96) |
| 2022 | $98.74 | 5 | Janssen Biotech, Inc. ($53.99) |
| 2021 | $322.17 | 23 | AbbVie Inc. ($139.26) |
| 2020 | $95.25 | 6 | PFIZER INC. ($44.30) |
| 2019 | $394.20 | 14 | AbbVie, Inc. ($150.18) |
| 2018 | $328.67 | 26 | AbbVie, Inc. ($208.00) |
| 2017 | $658.09 | 58 | Valeant Pharmaceuticals North America LLC ($248.85) |
All Payment Transactions
157 individual payment records from CMS Open Payments — Page 1 of 7
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 04/18/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $17.82 | General |
| Category: IMMUNOLOGY | ||||||
| 02/29/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $17.96 | General |
| Category: IMMUNOLOGY | ||||||
| 02/06/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $20.88 | General |
| Category: IMMUNOLOGY | ||||||
| 01/24/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $17.92 | General |
| Category: IMMUNOLOGY | ||||||
| 12/12/2023 | PFIZER INC. | XELJANZ (Drug), VELSIPITY | Food and Beverage | In-kind items and services | $27.16 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 11/15/2023 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $18.07 | General |
| Category: IMMUNOLOGY | ||||||
| 10/18/2023 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $6.29 | General |
| Category: IMMUNOLOGY | ||||||
| 10/12/2023 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $12.87 | General |
| Category: IMMUNOLOGY | ||||||
| 09/01/2023 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $11.31 | General |
| Category: IMMUNOLOGY | ||||||
| 08/31/2023 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $84.89 | General |
| Category: IMMUNOLOGY | ||||||
| 08/15/2023 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $1.48 | General |
| Category: IMMUNOLOGY | ||||||
| 07/06/2023 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $19.78 | General |
| Category: IMMUNOLOGY | ||||||
| 06/21/2023 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $10.39 | General |
| Category: IMMUNOLOGY | ||||||
| 06/07/2023 | INTERCEPT PHARMACEUTICALS, INC. | OCALIVA (Drug) | Food and Beverage | In-kind items and services | $16.59 | General |
| Category: Hepatology / Gastroenterology | ||||||
| 05/25/2023 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $10.00 | General |
| Category: IMMUNOLOGY | ||||||
| 05/11/2023 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $17.91 | General |
| Category: IMMUNOLOGY | ||||||
| 05/03/2023 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $4.00 | General |
| Category: IMMUNOLOGY | ||||||
| 04/12/2023 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $1.56 | General |
| Category: IMMUNOLOGY | ||||||
| 04/12/2023 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $1.19 | General |
| Category: IMMUNOLOGY | ||||||
| 03/21/2023 | INTERCEPT PHARMACEUTICALS, INC. | OCALIVA (Drug) | Food and Beverage | In-kind items and services | $16.35 | General |
| Category: Hepatology / Gastroenterology | ||||||
| 02/15/2023 | INTERCEPT PHARMACEUTICALS, INC. | OCALIVA (Drug) | Food and Beverage | In-kind items and services | $13.59 | General |
| Category: Hepatology / Gastroenterology | ||||||
| 01/25/2023 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $15.79 | General |
| Category: IMMUNOLOGY | ||||||
| 01/19/2023 | INTERCEPT PHARMACEUTICALS, INC. | OCALIVA (Drug) | Food and Beverage | In-kind items and services | $15.04 | General |
| Category: Hepatology / Gastroenterology | ||||||
| 01/18/2023 | QOL Medical, LLC | Sucraid (Drug) | Food and Beverage | Cash or cash equivalent | $24.66 | General |
| Category: THERAPY FOR CSID | ||||||
| 01/12/2023 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $12.43 | General |
| Category: IMMUNOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 12 | 707 | 743 | $404,558 | $81,313 |
| 2022 | 15 | 759 | 795 | $398,897 | $77,601 |
| 2021 | 15 | 881 | 934 | $424,035 | $92,762 |
| 2020 | 17 | 944 | 1,080 | $459,410 | $101,800 |
Total Patients
3,291
Total Services
3,552
Medicare Billing
$353,477
Procedure Codes
64
All Medicare Procedures & Services
64 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 128 | 132 | $107,420 | $25,104 | 23.4% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 122 | 123 | $68,279 | $12,955 | 19.0% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 130 | 134 | $102,905 | $9,771 | 9.5% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2023 | 44 | 44 | $34,850 | $7,067 | 20.3% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 66 | 70 | $18,438 | $6,705 | 36.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 55 | 59 | $12,905 | $4,836 | 37.5% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 36 | 53 | $9,214 | $3,080 | 33.4% |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 2023 | 18 | 18 | $14,778 | $2,948 | 19.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 44 | 45 | $6,464 | $2,670 | 41.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 15 | 15 | $4,858 | $1,819 | 37.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2023 | 16 | 16 | $5,208 | $1,588 | 30.5% |
| 43235 | Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 18 | 19 | $7,598 | $1,395 | 18.4% |
| 43248 | Insertion of guide wire with dilation of esophagus using a flexible endoscope | Facility | 2023 | 15 | 15 | $11,641 | $1,374 | 11.8% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2022 | 145 | 145 | $115,600 | $22,597 | 19.5% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2022 | 108 | 108 | $56,880 | $8,256 | 14.5% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 120 | 121 | $81,823 | $8,075 | 9.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 70 | 76 | $16,340 | $6,206 | 38.0% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2022 | 38 | 38 | $29,110 | $6,163 | 21.2% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 52 | 52 | $13,416 | $5,301 | 39.5% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 59 | 85 | $14,450 | $4,585 | 31.7% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 17 | 17 | $6,460 | $2,557 | 39.6% |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 2022 | 15 | 15 | $11,495 | $2,433 | 21.2% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Facility | 2022 | 17 | 18 | $9,900 | $2,255 | 22.8% |
| 43248 | Insertion of guide wire with dilation of esophagus using a flexible endoscope | Facility | 2022 | 20 | 20 | $17,892 | $2,169 | 12.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 32 | 34 | $4,760 | $2,072 | 43.5% |
About Dr. Stella Quiason, M.D
Dr. Stella Quiason, M.D is a Specialist healthcare provider based in Olathe, Kansas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/16/2006. The National Provider Identifier (NPI) number assigned to this provider is 1770500795.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Stella Quiason, M.D has received a total of $2,313 in payments from pharmaceutical and medical device companies, with $74.58 received in 2024. These payments were reported across 157 transactions from 17 companies. The most common payment nature is "Food and Beverage" ($2,306).
As a Medicare-enrolled provider, Quiason has provided services to 3,291 Medicare beneficiaries, totaling 3,552 services with total Medicare billing of $353,477. Data is available for 4 years (2020–2023), covering 64 distinct procedure/service records.
Ad
Practice Information
- Specialty Specialist
- Location Olathe, KS
- Active Since 07/16/2006
- Last Updated 09/21/2011
- Taxonomy Code 174400000X
- Entity Type Individual
- NPI Number 1770500795
Products in Payments
- Humira (Biological) $407.95
- STELARA (Biological) $243.86
- XIFAXAN (Drug) $158.94
- RINVOQ (Biological) $155.90
- HUMIRA (Biological) $154.75
- SKYRIZI (Biological) $146.64
- XELJANZ (Drug) $140.30
- VIBERZI (Drug) $131.26
- APRISO (Drug) $113.94
- LINZESS (Drug) $65.69
- OCALIVA (Drug) $61.57
- MOVIPREP (Drug) $50.03
- DIFICID (Drug) $48.46
- Creon (Drug) $36.80
- XIFAXANIBSD (Drug) $34.40
- INFLECTRA (Biological) $28.32
- Alinia Tablets 500mg 30 count bottle (Drug) $25.31
- Sucraid (Drug) $24.66
- ZENPEP (Drug) $24.33
- REMICADE (Biological) $21.56
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Specialist Doctors in Olathe
Mrs. Emily Mathiesen, M.d, M.D
Specialist — Payments: $2,211
Specialist $2,211
James Lee, Lscsw, Acsw, Bcd,, LSCSW, ACSW, BCD,
Specialist
Specialist
Nahid Shavakhi, Arnp, ARNP
Specialist
Specialist
Lynn Kaufman
Specialist
Specialist
Vonetta Mcclunie
Specialist
Specialist
Rhonda Linder, O.t, O.T
Specialist
Specialist